Press Release – New York, NY – July 21, 2026 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals, in its recently announced up to $4 million at-the-market offering.
Aegis Capital Corp. is acting as sales agent for the offering.
The SRFC team was led by partners Gregory Sichenzia and Jeff Cahlon, with associate Benasz Hansotia.